MORC3 and calcinosis: Anti-NXP-2 autoantibodies show a bimodal spectrum of clinical association, with calcinosis being more frequent in younger patients and cancer more common in the elderly [90], especially in male gender [88], even though with a lower prevalence when compared to anti-TIF-1 [87, 88].